Understanding the patient journey in sickle cell disease
The Challenge
A global healthcare client required a deeper understanding of the lived experience of patients with sickle cell disease, a complex, high-burden condition often shaped by both clinical and socio-economic factors.
The client needed to:
- Build a holistic view of the patient journey, from diagnosis through ongoing management
- Understand the clinical, emotional, and social impact of living with the condition
- Identify key stakeholders influencing patient experience and outcomes
- Uncover areas where they could better support patients and improve engagement
The challenge was compounded by the nature of the disease: a hard-to-reach and often underrepresented patient population, with experiences shaped by stigma, inequality, and variability in care models.
Our Approach
Bryter designed a qualitative-led research programme focused on capturing the authentic patient voice.
Deep patient journey mapping
We explored the full patient pathway, including:
- Diagnosis and early engagement with healthcare systems
- Ongoing disease management and treatment experiences
- Interactions with healthcare professionals and support networks
This allowed us to build a detailed, end-to-end view of the patient experience.
Accessing hard-to-reach populations
Recognising the challenges of recruitment, Bryter leveraged specialist approaches to engage:
- Patients across varied geographies and care settings
- Individuals with diverse lived experiences and disease severity
This ensured insight reflected the breadth and diversity of real-world experiences
Capturing the emotional reality
We used in-depth qualitative techniques to uncover:
- The psychological and emotional burden of living with sickle cell
- The impact of stigma and external circumstances
- The role of family, caregivers, and community in shaping experiences
Filmed outputs and immersive storytelling were used to bring these insights to life for stakeholders.
The Outcome
Bryter delivered a comprehensive set of outputs that translated patient understanding into actionable strategy.
This included:
- A detailed patient journey map, highlighting key pain points and intervention opportunities
- Identification of priority stakeholders and influence points
- Clear guidance on how the client could better align its proposition to patient needs
- Immersive, insight-led storytelling to drive internal engagement and empathy
The research provided a powerful evidence base to inform both product strategy and patient support initiatives, with:
- Greater internal understanding of the real-world patient experience
- Improved ability to identify unmet needs and support opportunities
- Stronger alignment between commercial strategy and patient reality
- Increased organisational focus on patient-centric decision making
Learn more about how market research and insights can build a deeper understanding of the lives of patients, support in testing and development of new therapies and build effective marketing strategies in our 'ultimate guide to pharmaceutical market research and insights'
Related case studies
Supporting rare disease market entry: Building a European market access strategy
Optimising patient communications: Adcept and message testing for a Multiple Myeloma campaign